Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 34.75
-0.28 (-0.80%)
Sep 24, 2026, 12:45 PM IST
Fischer Medical Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,671 | 3,086 | 1,107 | 209.81 | 1.8 | - |
| 3,671 | 3,086 | 1,107 | 209.81 | 1.8 | - | |
Revenue Growth | 195.95% | 178.75% | 427.61% | 11588.75% | 8.79% | - |
Cost of Revenue | 2,410 | 1,962 | 917.59 | 165.76 | - | - |
Gross Profit | 1,260 | 1,124 | 189.4 | 44.05 | 1.8 | - |
Selling, General & Admin | 164.54 | 164.38 | 47 | 4.7 | 0.63 | 0.9 |
Other Operating Expenses | 593.24 | 494.85 | 108.97 | 20.75 | 1.01 | 0.98 |
Operating Expenses | 793.48 | 689.02 | 172.29 | 27.27 | 1.64 | 1.89 |
Operating Income | 466.62 | 434.59 | 17.11 | 16.78 | 0.15 | -1.89 |
Interest Expense | -87.16 | -49.75 | -4.03 | -0.68 | -0.17 | -0.09 |
Interest & Investment Income | - | 55.55 | 9.27 | 4.95 | - | - |
Earnings From Equity Investments | 1.12 | -2.22 | -4.87 | - | - | - |
Currency Exchange Gain (Loss) | - | 6.64 | 0.69 | - | - | - |
Other Non Operating Income (Expenses) | 63.32 | 51.95 | 1.97 | 0.06 | -0 | - |
EBT Excluding Unusual Items | 443.89 | 496.76 | 20.15 | 21.11 | -0.01 | -1.97 |
Gain (Loss) on Sale of Investments | - | -32.32 | - | - | - | - |
Asset Writedown | - | -0.02 | - | - | - | - |
Pretax Income | 443.89 | 464.84 | 22.23 | 21.11 | -0.01 | -1.97 |
Income Tax Expense | 142.16 | 154.64 | 10.15 | 2.73 | 0.35 | 0.35 |
Earnings From Continuing Operations | 301.73 | 310.2 | 12.08 | 18.38 | -0.37 | -2.33 |
Minority Interest in Earnings | - | 11.9 | 2.74 | -4.6 | - | - |
Net Income | 301.73 | 322.1 | 14.82 | 13.78 | -0.37 | -2.33 |
Net Income to Common | 301.73 | 322.1 | 14.82 | 13.78 | -0.37 | -2.33 |
Net Income Growth | 376.42% | 2073.55% | 7.51% | - | - | - |
Shares Outstanding (Basic) | 657 | 651 | 549 | 111 | 2 | 2 |
Shares Outstanding (Diluted) | 710 | 694 | 549 | 169 | 2 | 2 |
Shares Change | - | 26.45% | 223.98% | 9752.91% | - | - |
EPS (Basic) | 0.46 | 0.49 | 0.03 | 0.12 | -0.21 | -1.35 |
EPS (Diluted) | 0.42 | 0.46 | 0.03 | 0.11 | -0.21 | -1.35 |
EPS Growth | - | 1618.96% | -75.01% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,298 | -922.39 | -78.37 | -1.46 | -1.77 |
Free Cash Flow Per Share | - | -1.87 | -1.68 | -0.46 | -0.85 | -1.03 |
Dividend Per Share | - | 0.050 | 0.050 | - | - | - |
Dividend Growth | - | 0% | - | - | - | - |
Gross Margin | 34.33% | 36.41% | 17.11% | 20.99% | 100.00% | - |
Operating Margin | 12.71% | 14.08% | 1.55% | 8.00% | 8.52% | - |
Profit Margin | 8.22% | 10.44% | 1.34% | 6.57% | -20.33% | - |
Free Cash Flow Margin | - | -42.06% | -83.32% | -37.35% | -81.28% | - |
EBITDA | 485.16 | 448.87 | 23.69 | 17.68 | - | - |
EBITDA Margin | 13.22% | 14.55% | 2.14% | 8.43% | - | - |
D&A For EBITDA | 18.54 | 14.29 | 6.58 | 0.91 | - | - |
EBIT | 466.62 | 434.59 | 17.11 | 16.78 | 0.15 | -1.89 |
EBIT Margin | 12.71% | 14.08% | 1.55% | 8.00% | 8.52% | - |
Effective Tax Rate | 32.03% | 33.27% | 45.65% | 12.95% | - | - |
Revenue as Reported | 3,734 | 3,209 | 1,122 | 214.83 | 1.8 | - |
Advertising Expenses | - | 9.39 | 11.85 | - | - | - |